Detalles de la búsqueda
1.
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(11): 2197-2203, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30016656
2.
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
Eur J Haematol
; 99(6): 532-535, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28895206
3.
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 21(8): 1413-7, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25842049
4.
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
Am J Hematol
; 89(4): 395-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24375514
5.
Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
Am J Hematol
; 88(10): 831-7, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23760779
6.
Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia.
Am J Hematol
; 87(7): 687-91, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22473898
7.
The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromes.
Leuk Lymphoma
; 56(2): 390-4, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24844364
8.
Management of imatinib-resistant patients with chronic myeloid leukemia.
Ther Adv Hematol
; 4(2): 103-17, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23610618
9.
Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome.
Clin Lymphoma Myeloma Leuk
; 13 Suppl 2: S289-94, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23969308
10.
Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure.
Clin Lymphoma Myeloma Leuk
; 11 Suppl 1: S101-10, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22035738
11.
Dasatinib combined with interferon-alfa induces a complete cytogenetic response and major molecular response in a patient with chronic myelogenous leukemia harboring the T315I BCR-ABL1 mutation.
Clin Lymphoma Myeloma Leuk
; 11 Suppl 1: S111-3, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22035739
Resultados
1 -
11
de 11
1
Próxima >
>>